Skip to main content
SpringerLink
Log in

Prevalence of hepatitis C virus antibody in a liver transplantation population

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The development of a serologic assay to detect antibodies directed at an antigen (C-100-3) of the hepatitis C virus (anti-HCV) has been a major breakthrough in the long search for causative agents of non-A, non-B (NANB) hepatitis. The frequency of HCV in those who have end-stage liver disease is not known. Moreover, the rate of recurrence after liver transplantation (OLTx) and the rate of acquisition of new HCV infection as a result of the OLTx experience is as yet unknown. This study was performed in an attempt to answer these questions. The prevalence of HCV in 372 patients undergoing OLTx at the University of Pittsburgh was determined. Those transplanted for HBV-related liver disease with hepatoma had the highest rate of HCV antibody positivity (45.4%) followed by those with metabolic liver disease (42.5%), putative NANB liver disease (41.4%), and cryptogenic cirrhosis (20.9%); those with cholestatic liver disease exhibited the lowest rate (16.2%). HCV antibody was positive in only 26.3% of patients with hepatoma. Of those patients who were negative prior to transplantation, 12.2% acquired HCV antibody post-OLTx. In the putative NANB group, no difference was detected in the AST and ALT prior to transplantation in either the HCV antibody-positive or-negative patients. In patients with cryptogenic cirrhosis, those who were positive for HCV antibody had higher transaminase levels prior to transplantation than did those patients who were HCV antibody negative.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jacobson IM, Friedman LS: Viral Hepatitis. Curr Opin Infect Dis 2:272–286, 1989

    Google Scholar 

  2. Dienstag JL: Non A non B hepatitis. I. Recognition, epidemiology and clinical features. Gastroenterology 84:439–462, 1983

    Google Scholar 

  3. Dienstag JL: Non A non B hepatitis. II. Experimental transmission, putative virus agents and markers and prevention. Gastroenterology 84:743–768, 1983

    Google Scholar 

  4. Fattovich G, Tagger A, Brollo L, Pontisso P, Realdi G, Ferroni P, Alberti A: Liver disease in anti-HBe positive chronic HBsAg carriers and hepatitis C virus. Lancet 2:797–798, 1989

    Google Scholar 

  5. Francis DP, Hadler SC, Pendergast TJ, Peterson E, Ginsberg MM, Lookabaugh C, Holmes JR, Maynard JE: Occurrence of hepatitis A, B, and non-A/non-B in the United States. CDC Sentinal County Hepatitis Study 1. Am J Med 76:69–74, 1984

    Google Scholar 

  6. Stevens CE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Kahn R, Werch J, Edwards V: Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. Ann Intern Med 101:733–738, 1984

    Google Scholar 

  7. Mosley JW, Redeker AG, Feinstone SM, Purcell RH: Multiple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med 296:75–78, 1977

    Google Scholar 

  8. Galbraith RM, Portmann B, Eddleston ALWF, Williams R, Gower PE: Chronic liver disease developing after outbreak of HGsAg-negative hepatitis in haemodialysis unit. Lancet 2:886–890, 1975

    Google Scholar 

  9. Miyamura T, Saito I, Katayama T, Kikuchi S, Tateda A, Houghton M, Choo Q-L, Kuo G: Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci USA 87:983–987, 1990

    Google Scholar 

  10. Marwick C, Skolnick A: Research seems to be gaining upper hand on what's been called non-A, non-B hepatitis. JAMA 263:14–17, 1990

    Google Scholar 

  11. Mosley JW, Aach RD, Hollinger FB, Stevens CE, Barbosa LH, Nemo GJ, Holland PV, Bancroft WH, Zimmerman HJ, Kuo G, Choo Q-L, Houghton M: Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA 263:77–78, 1990

    Google Scholar 

  12. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Rediker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M: An assay for circulating antibodies to a major etiologic virus of human non A, non B hepatitis. Science 244:362–364, 1989

    Google Scholar 

  13. Alter MJ, Sampliner RE: Hepatitis C—and miles to go before we sleep. N Engl J Med 321:1538–1540, 1989

    Google Scholar 

  14. Mortimer PP, Cohen BJ, Litton PA, Vandervelde EM, Bassendine MF, Brind AM, Hambling MH: Hepatitis C virus antibody. Lancet 2:798, 1989

    Google Scholar 

  15. van der Poel CL, Reesink HW, Lelie PN, Leentvaar-Kuypers A, Choo Q-L, Kuo G, Houghton M: Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet 1:297–298, 1989

    Google Scholar 

  16. Cash JD, McClelland DBL, Urbaniak SJ, Brookes E, Follett EAC: Screening for hepatitis C virus antibody. Lancet 1:505, 1989

    Google Scholar 

  17. Contreras M, Barbara JAJ: Screening for hepatitis C virus antibody. Lancet 1:505, 1989

    Google Scholar 

  18. Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U, Zauli D, Bianchi FB: Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1:258–259, 1990

    Google Scholar 

  19. Billanti S, Barbara L, Miglioli M, Bonino F: Hepatitis C virus: A possible cause of chronic hepatitis in alcoholics. Lancet 2:1390–1391, 1989

    Google Scholar 

  20. Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera JC, Gonzalez A, Hernandez JM, Roget M, Vargas V, Genesca J, Buti M, Guardia J: Hepatitis C virus among risk groups in Spain. Lancet 1:294–297, 1989

    Google Scholar 

  21. Tabor E: Hepatocellular carcinoma: Possible etiologies in patients without serologic evidence of hepatitis B virus infection. J Med Virol 27:1–6, 1989

    Google Scholar 

  22. Simonetti RG, Cottone M, Craxi M, Pagliaro L, Rapicetta M, Chionne P, Costantino A: Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet 2:1338, 1989

    Google Scholar 

  23. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, Vall M, Bruguera M, Bru C, Castillo R, Rodes J: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2:1004–1006, 1989

    Google Scholar 

  24. Kiyosawa K, Akahane Y, Nagata A, Furata S: Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol 79:777–781, 1984

    Google Scholar 

  25. Grendele M, Gridelli B, Colledan M, Rossi G, Fassati LR, Ferla G, Lunghi G, Galmarini D: Hepatitis C virus infection and liver transplantation. Lancet 2:1221–1222, 1989

    Google Scholar 

  26. Donovan JP, Markin RS, Zetterman RK, Sorrell MF, Stratta RJ, Wood RP, Langnas AN, Shaw BW Jr.: Non A, non B hepatitis after orthotopic liver transplantation. Hepatology 10:569A, 1989

    Google Scholar 

  27. Ortho Diagnostic Systems, Inc. Directions for use: Ortho HCV antibody ELISA test system. Available from Johnson and Johnson, Raritan, New Jersey

  28. Stevens CE, Taylor PE, Pindyck J, Choo Q-L, Bradley DW, Kuo G, Houghton M: Epidemiology of hepatitis C virus: A preliminary study in volunteer blood donors. JAMA 263:49–53, 1990

    Google Scholar 

  29. Reesink HW, van der Poel CL: Blood transfusion and hepatitis: still a threat? Blut 58:1–6, 1989

    Google Scholar 

  30. Swinbanks, D: Blood donors to be screened. Nature 342:467 1989

    Google Scholar 

  31. Sirchia G, Bellobuono A, Giovanetti A, Marconi M: Antibodies to hepatitis C virus in Italian blood donors. Lancet 2:797, 1989

    Google Scholar 

  32. Janot C, Courouce AM, Maniez M: Antibodies to hepatitis C virus in French blood donors. Lancet 2:796–797, 1989

    Google Scholar 

  33. Marugan RB, Zamora C, Moreno A, Erdozaiu JC, Hernandez FP, Roman ALS: Serum alanine aminotransferase (ALT) assay and incidence of post-transfusion non-A, non-B hepatitis. Transfusion 29:751, 1989

    Google Scholar 

  34. Koziol DE, Holland PV, Alling DW, Melpolder JC, Solomon RE, Purcell RH, Hudson LM, Shoup FJ, Krakauer H, Alter HJ: Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 104:488–495, 1986

    Google Scholar 

  35. Aach RD, Szmuness W, Mosley JW, Hollinger FB, ahn RA, Stevens CE, Edwards VM, Werch J: Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. N Engl J Med 304:990–994, 1981

    Google Scholar 

  36. Alter HJ, Purcell RH, Holland PV, Alling DW, Koziol DE: Donor transaminase and recipient hepatitis-impact on blood transfusion services. JAMA 246:630–634, 1981

    Google Scholar 

  37. Tateda A, Kikuchi K, Numazaki Y, Shirachi R, Ishida N: Non-B hepatitis in Japanese recipients of blood transfusions: Clinical and serologic studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen. J Infect Dis 139:511–518, 1979

    Google Scholar 

  38. Koretz RL, Stone O, Mousa M, Gitnik GL: Non-A, non-B posttransfusion hepatitis—a decade later. Gastroenterology 88:1251–1254, 1985

    Google Scholar 

  39. Lewis JH, Bontempo FA, Cornell F, Kiss JE, Larson P, Ragni MV, Rice EO, Spero JA, Starzl TE: Blood use, in liver transplantation. Transfusion 27:222–225, 1987

    Google Scholar 

  40. Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, Rosenblatt J, Choo Q-L, Houghton M: Detection of hepatitis C viral sequences in non A, non B hepatitis. Lancet 335:1–3, 1990

    Google Scholar 

  41. Alter HJ: Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non A, non B hepatitis. N Engl J Med 321:1494–1500, 1989

    Google Scholar 

  42. Sansonno D, Dammacco F: Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryptogenic chronic liver disease. Lancet 2:789–799, 1989

    Google Scholar 

  43. Mitsson L, Weiland O, Glaumann H: Chronic non-A, non-B hepatitis developed after transfusions, illicit self-injections or sporadically. Outcome during long-term follow-up—a comparison. Liver 9:120–127, 1989

    Google Scholar 

  44. Gust I, Nicholson S, Dimitrakakis M, Hoy J, Lucas R: Prevalence of infection with hepatitis C virus in Australia. Med J Aust 151:719, 1989

    Google Scholar 

  45. Realdi G, Alberti A, Rugge M, Rigoli AM, Tremolada F, Schivazappa L, Ruol A: Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis. Gut 23:270–275, 1982

    Google Scholar 

  46. Alter MJ, Gerety RJ, Smallwood LA, Sampliner RE, Tabor E, Deinhardt F, Frösner G, Matanoski GM: Sporadic non-A, non-B hepatitis: Frequency and epidemiology in an urban US population. J Infect Dis 145:886–893, 1982

    Google Scholar 

  47. Alter HJ, Purcell RH, Feinstone SH, Holland PV, Morrow AG: Non-A, non-B hepatitis: A review and interim report of an ongoing prospective study.In Viral Hepatitis: Etiology, Epidemiology, Pathogenesis and Prevention. GN Vyas, SW Cohen, R Schmid (eds). Philadelphia, Franklin Institute Press, 1978, pp 121–138

    Google Scholar 

  48. Rumi MG, Colombo M, Gringeri A, Mannucci PM: High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels. Ann Intern Med 112:379–380, 1990

    Google Scholar 

  49. Noel L, Guerois C, Maisonneuve P, Verroust F, Laurian Y: Antibodies to hepatitis C virus in haemophilia. Lancet 2:560, 1989

    Google Scholar 

  50. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH: Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 97:1559–1561, 1989

    Google Scholar 

  51. Todo S, Demetris AJ, Van Thiel DH, Teperman L, Fung JJ, Starzl TE: Orthotopic liver transplantation for patients with hepatitis B virus (HBV) related liver disease. Hepatology 13:619–626, 1991

    Google Scholar 

  52. Schvarcz R, Wiland O, Wejstal R, Norkrans G, Fryden A, Foberg U: A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: No correlation of outcome to presence of hepatitis C virus antibodies. Scand J Infect Dis 21:617–625, 1989

    Google Scholar 

  53. Davis GL, Balant LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, the Hepatitis International Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 321:1501–1506, 1989

    Google Scholar 

  54. DiBisceglie AM, Martin P, Kassianides C, Lister-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH: Recombinant interferon alfa therapy for chronic hepatitis C. N Engl J Med 321:1506–1510, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Surgery, Graduate School of Public Health, University of Pittsburgh School of Medicine, 15261, Pittsburgh, Pennsylvania

    Lobna El-Ashmawy MD, Tarek Hassanein MD, Judith S. Gavaler PhD &  David H. Van Thiel MD

  2. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh School of Medicine, 15261, Pittsburgh, Pennsylvania

    Lobna El-Ashmawy MD, Tarek Hassanein MD, Judith S. Gavaler PhD &  David H. Van Thiel MD

Authors
  1. Lobna El-Ashmawy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tarek Hassanein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Judith S. Gavaler PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David H. Van Thiel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported in part by grants from NIDDK 32556. Both LE-A and TH were recipients of a Peace Fellowship from AID.

Rights and permissions

Reprints and permissions

About this article

Cite this article

El-Ashmawy, L., Hassanein, T., Gavaler, J.S. et al. Prevalence of hepatitis C virus antibody in a liver transplantation population. Digest Dis Sci 37, 1110–1115 (1992). https://doi.org/10.1007/BF01300295

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01300295

Key Words

Search

Navigation